CRISPR Therapeutics AG
USD56.35
+1.43 (+2.60%)
CEO
Samarth Kulkarni
IPO Date
2016-10-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CH
Open
$55.06
Prev. Close
$54.92
Day Low
$53.77
Day High
$57.80
52W Low
$44.12
52W High
$78.48
Market Cap
$5.43B
Volume
1.81M
| 13,000 |
| $51.84 |
| 9 Jun 2026 | Fardis Maria | director | A-Award | Acquired | 13,000 | $51.84 |
| 9 Jun 2026 | Fleming Harold Edward | director | A-Award | Acquired | 13,000 | $51.84 |
| 9 Jun 2026 | Greene John | director | A-Award | Acquired | 13,000 | $51.84 |
| 9 Jun 2026 | High Katherine A | director | A-Award | Acquired | 13,000 | $51.84 |
| 9 Jun 2026 | Mahatme Sandesh | director | A-Award | Acquired | 13,000 | $51.84 |
| 9 Jun 2026 | Morrison Briggs | director | A-Award | Acquired | 13,000 | $51.84 |
| 9 Jun 2026 | Rommel Christian | director | A-Award | Acquired | 13,000 | $51.84 |
| 9 Jun 2026 | Treco Douglas A | director | A-Award | Acquired | 13,000 | $51.84 |
| $15,001 - $50,000 |
| 8 Nov 2017 | James Inhofe | James Inhofe | Purchase | $15,001 - $50,000 |
| Disclosed | Representative | Office | Type | Amount |
|---|---|---|---|---|
| 5 Oct 2021 | Thomas Suozzi | Thomas Suozzi | Sale (Full) | $50,001 - $100,000 |
| 19 Feb 2021 | Marjorie Taylor Greene | Marjorie Taylor Greene | Purchase | $1,001 - $15,000 |